Differentiated treatment of multi-resistant Gram-negative pathogens in intensive care units
Multi-resistant Gram-negative pathogens will pose an enormous challenge to medicine in the coming years. Therefore, the World Health Organization emphasises that there is a great need for the development of new antimicrobial drugs. At the same time, intensivists must be prepared to treat complex inf...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch Englisch |
| Veröffentlicht: |
September 2021
|
| In: |
Anästhesiologie & Intensivmedizin
Year: 2021, Jahrgang: 62, Pages: 398-409 |
| ISSN: | 1439-0256 |
| DOI: | 10.19224/ai2021.398 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.19224/ai2021.398 Verlag, lizenzpflichtig, Volltext: https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DynamicDOIArticle&SrcApp=WOS&KeyAID=10.19224%2Fai2021.398&DestApp=DOI&SrcAppSID=F2SIIFIUYl9XpoPqogV&SrcJTitle=ANASTHESIOLOGIE+%26+INTENSIVMEDIZIN 
|
| Verfasserangaben: | T. Schmoch, A. Heininger, D. Richter, T. Brenner, M.A. Weigand |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1776027310 | ||
| 003 | DE-627 | ||
| 005 | 20230428085449.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211103s2021 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.19224/ai2021.398 |2 doi | |
| 035 | |a (DE-627)1776027310 | ||
| 035 | |a (DE-599)KXP1776027310 | ||
| 035 | |a (OCoLC)1341423268 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schmoch, Thomas |d 1985- |e VerfasserIn |0 (DE-588)1072523493 |0 (DE-627)827680546 |0 (DE-576)433996331 |4 aut | |
| 245 | 1 | 0 | |a Differentiated treatment of multi-resistant Gram-negative pathogens in intensive care units |c T. Schmoch, A. Heininger, D. Richter, T. Brenner, M.A. Weigand |
| 264 | 1 | |c September 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.11.2021 | ||
| 520 | |a Multi-resistant Gram-negative pathogens will pose an enormous challenge to medicine in the coming years. Therefore, the World Health Organization emphasises that there is a great need for the development of new antimicrobial drugs. At the same time, intensivists must be prepared to treat complex infections with multi-resistant pathogens more often. As a consequence, a sound knowledge of the resistance mechanisms and the available antimicrobial drugs is essential. In this context, new beta-lactam antibiotics (and combinations), such as ceftolozane / tazobactam or ceftazidime / avibactam, but also the combinations of / with meropenem / vaborbactam, aztreonam / avibactam or imipenem / cilastatin / relebactam, should be mentioned. Their availability is to be welcomed, especially with regard to their reduced toxicity in comparison to colistin-based therapies. Moreover, this review comments on cefiderocol, a new drug which could revolutionise the treatment of multi-resistant Gram-negative germs. This review article intends to give the reader an overview of the resistance mechanisms prevalent in Germany and the respective appropriate treatment options. | ||
| 650 | 4 | |a aerosolized colistin | |
| 650 | 4 | |a beta-lactamase inhibitor | |
| 650 | 4 | |a Cefiderocol | |
| 650 | 4 | |a Ceftazidime / Avibactam | |
| 650 | 4 | |a ceftazidime-avibactam | |
| 650 | 4 | |a Ceftolozane / Tazobactam | |
| 650 | 4 | |a double-blind | |
| 650 | 4 | |a in-vitro activity | |
| 650 | 4 | |a klebsiella-pneumoniae | |
| 650 | 4 | |a meropenem | |
| 650 | 4 | |a Multi-resistant Gram-negative | |
| 650 | 4 | |a nosocomial pneumonia | |
| 650 | 4 | |a piperacillin-tazobactam | |
| 650 | 4 | |a pseudomonas-aeruginosa | |
| 650 | 4 | |a Sepsis | |
| 700 | 1 | |a Heininger, Alexandra |d 1962- |e VerfasserIn |0 (DE-588)112271219 |0 (DE-627)58327725X |0 (DE-576)289726204 |4 aut | |
| 700 | 1 | |a Richter, Daniel |d 1984- |e VerfasserIn |0 (DE-588)102975571X |0 (DE-627)734015259 |0 (DE-576)37760304X |4 aut | |
| 700 | 1 | |a Brenner, Thorsten |d 1978- |e VerfasserIn |0 (DE-588)130125709 |0 (DE-627)491713363 |0 (DE-576)189360607 |4 aut | |
| 700 | 1 | |a Weigand, Markus A. |d 1967- |e VerfasserIn |0 (DE-588)1064970435 |0 (DE-627)815375239 |0 (DE-576)424658666 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anästhesiologie & Intensivmedizin |d Ebelsbach : Aktiv Dr. und Verl., 1978 |g 62(2021) vom: Sept., Seite 398-409 |h Online-Ressource |w (DE-627)503718459 |w (DE-600)2211357-5 |w (DE-576)25261450X |x 1439-0256 |7 nnas |a Differentiated treatment of multi-resistant Gram-negative pathogens in intensive care units |
| 773 | 1 | 8 | |g volume:62 |g year:2021 |g month:09 |g pages:398-409 |g extent:12 |a Differentiated treatment of multi-resistant Gram-negative pathogens in intensive care units |
| 856 | 4 | 0 | |u https://doi.org/10.19224/ai2021.398 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DynamicDOIArticle&SrcApp=WOS&KeyAID=10.19224%2Fai2021.398&DestApp=DOI&SrcAppSID=F2SIIFIUYl9XpoPqogV&SrcJTitle=ANASTHESIOLOGIE+%26+INTENSIVMEDIZIN |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211103 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1064970435 |a Weigand, Markus A. |m 1064970435:Weigand, Markus A. |d 910000 |d 910300 |e 910000PW1064970435 |e 910300PW1064970435 |k 0/910000/ |k 1/910000/910300/ |p 5 |y j | ||
| 998 | |g 130125709 |a Brenner, Thorsten |m 130125709:Brenner, Thorsten |d 50000 |e 50000PB130125709 |k 0/50000/ |p 4 | ||
| 998 | |g 102975571X |a Richter, Daniel |m 102975571X:Richter, Daniel |d 910000 |d 910300 |e 910000PR102975571X |e 910300PR102975571X |k 0/910000/ |k 1/910000/910300/ |p 3 | ||
| 998 | |g 112271219 |a Heininger, Alexandra |m 112271219:Heininger, Alexandra |d 60000 |d 63200 |e 60000PH112271219 |e 63200PH112271219 |k 0/60000/ |k 1/60000/63200/ |p 2 | ||
| 998 | |g 1072523493 |a Schmoch, Thomas |m 1072523493:Schmoch, Thomas |d 50000 |e 50000PS1072523493 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1776027310 |e 3998837337 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["ger","eng"],"name":{"displayForm":["T. Schmoch, A. Heininger, D. Richter, T. Brenner, M.A. Weigand"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Differentiated treatment of multi-resistant Gram-negative pathogens in intensive care units","title":"Differentiated treatment of multi-resistant Gram-negative pathogens in intensive care units"}],"person":[{"family":"Schmoch","role":"aut","given":"Thomas","display":"Schmoch, Thomas"},{"display":"Heininger, Alexandra","given":"Alexandra","role":"aut","family":"Heininger"},{"family":"Richter","role":"aut","given":"Daniel","display":"Richter, Daniel"},{"role":"aut","display":"Brenner, Thorsten","given":"Thorsten","family":"Brenner"},{"family":"Weigand","role":"aut","given":"Markus A.","display":"Weigand, Markus A."}],"physDesc":[{"extent":"12 S."}],"id":{"doi":["10.19224/ai2021.398"],"eki":["1776027310"]},"note":["Gesehen am 03.11.2021"],"origin":[{"dateIssuedDisp":"September 2021","dateIssuedKey":"2021"}],"recId":"1776027310","relHost":[{"id":{"issn":["1439-0256"],"eki":["503718459"],"zdb":["2211357-5"]},"language":["ger"],"name":{"displayForm":["Hrsg.: Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI)"]},"recId":"503718459","origin":[{"publisherPlace":"Ebelsbach","dateIssuedKey":"1978","publisher":"Aktiv Dr. und Verl.","dateIssuedDisp":"1978-"}],"note":["Volltext auch als Teil einer Datenbank verfügbar","Gesehen am 02.09.2021"],"pubHistory":["19.1978,9 -"],"title":[{"subtitle":"offizielles Organ der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin, des Berufsverbandes Deutscher Anästhesisten und der Deutschen Akademie für Anästhesiologische Fortbildung","title_sort":"Anästhesiologie & Intensivmedizin","title":"Anästhesiologie & Intensivmedizin"}],"part":{"text":"62(2021) vom: Sept., Seite 398-409","year":"2021","pages":"398-409","volume":"62","extent":"12"},"disp":"Differentiated treatment of multi-resistant Gram-negative pathogens in intensive care unitsAnästhesiologie & Intensivmedizin","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"Anästhesiologie und Intensivmedizin"},{"title":"A & I"}]}]} | ||
| SRT | |a SCHMOCHTHODIFFERENTI2021 | ||